3
2
1

Malaysian Avarev company delegation visited and inspected the Yinfeng Life Science Foundation in Shandong Province

Release time:

2018-03-12

On March 12, 2018, five members led by Jones Bartholomew, CEO of Avarev Malaysia, visited and inspected the Yinfeng Life Science Foundation in Shandong Province. Song Xianshou, President of Yinfeng Biotechnology Group, and Pang Yong, Vice President, accompanied the exchange.

11

The delegation visited Shandong Provincial Cord Blood Bank and Shandong Yinfeng Life Science Research Institute, and gained a detailed understanding of the progress, technical strength, possibility of technological output, and laws and regulations of the foundation's funded project - Life Extension Plan. They also witnessed Yinfeng's qualifications and research achievements in cell tissue low-temperature preservation, low-temperature medical equipment research and development, and other aspects.
After the visit, both sides had a friendly discussion. Song Xianshou, the President of Yinfeng Biotechnology Group, introduced the industrial distribution of Yinfeng Biotechnology Group in the field of biomedical science. He hoped that both sides could combine their own characteristics and advantages to carry out in-depth cooperation and jointly promote the development of life sciences. Avarev stated that Yinfeng Biotech Group has made remarkable progress in the field of life sciences, with the Life Continuation Research Program leading the world's innovation trend. We look forward to further cooperation between the two parties and hope to have further communication and discussion in specific areas of cooperation in the future.

Latest developments

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology

According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.